Close Menu

NEW YORK (GenomeWeb) – Cypress, California-based DiaSorin Molecular said today that it has received CE marking for its Simplexa HSV 1/2 & VZV Universal Direct MDx assay designed for use on the firm's Liaison MDx instrument.

The assay uses cutaneous and mucocutaneous swab specimens for the direct detection and differentiation of DNA associated with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV).

Testing for VZV with HSV-1 and HSV-2 may enable clinicians to provide improved therapeutic decisions and advice, DiaSorin said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.